CivicaScript®, LLC, a nonprofit company dedicated to bringing low-cost generic medicines and biosimilars to U.S. patients, today announced the availability of two new products: insulin glargine-yfgn ...

CivicaScript, a nonprofit generic drug company, has launched insulin glargine-yfgn and ustekinumab-aauz, expanding its national portfolio of low-cost treatments. The insulin product, which is ...

California is the first state in the country to partner with a nonprofit to develop, produce and sell its own insulin.

As of January, California is the first state in the country to partner with a nonprofit to develop, produce and sell its own ...

The new year will begin with some first-of-their-kind laws in several states. Hawaii will become the first state to raise its ...

California’s health care landscape today would probably disappoint the Gavin Newsom who spent much of 2017 and 2018 campaigning to become governor.

SACRAMENTO, CA – Setting a national precedent, California will sell its own state-branded insulin, making life-saving diabetes medication affordable for millions. Governor Gavin Newsom announced that ...

The state’s CalRx Insulin Glargine will be available to consumers for a suggested retail price of $55 or less per five-pack of pens beginning Jan. 1, 2026. The insulin glargine pen agreement with ...

California Governor Insulin California Gov. Gavin Newsom listens media questions after announcing CalRx-branded insulin glargine pens available next Jan. 1, 2026, at a suggested retail price of no ...